4,4-Dichloro-3-(4-methylthiophenyl)-2-phenyl-2-cyclobuten-1-one | 186818-92-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4,4-Dichloro-3-(4-methylthiophenyl)-2-phenyl-2-cyclobuten-1-one
• 英文别名: 4,4-dichloro-3-(4-methylsulfanylphenyl)-2-phenylcyclobut-2-en-1-one
• CAS: 186818-92-8
• 化学式: C₁₇H₁₂Cl₂OS
• 分子量: 335.254
• InChiKey: ANJALBIXTFXNAO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  42.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4,4-Dichloro-3-(4-methylthiophenyl)-2-phenyl-2-cyclobuten-1-one 在 四甲基乙二胺 、 溶剂黄146 、 锌 作用下， 以 乙醇 为溶剂， 以27%的产率得到3-(4-(methylthio)phenyl)-2-phenylcyclobut-2-en-1-one
  参考文献：
  名称：

  Novel 1,2-diarylcyclobutenes: Selective and orally active cox-2 inhibitors

  摘要：

  A series of novel 2,3-diaryl-2-cyclobuten-1-ones have been synthesized and have been evaluated with respect to their ability to inhibit the isozymes of cyclooxygenase, COX-I and COX-2. 4,4-Dimethyl-2-phenyl-3- [4-(methylsulfonyl)phenyl]cyclobutenone 22 was found to be highly selective for inhibition of COX-2 and was orally active (ED(50) = 2.4 mg/kg) in the rat paw edema model. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00501-x
• 作为产物：
  描述：

  methyl(4-(phenylethynyl)phenyl)sulfane 、 三氯乙酰氯 在 锌铜偶 、 三氯氧磷 作用下， 以 乙醚 为溶剂， 以23%的产率得到4,4-Dichloro-3-(4-methylthiophenyl)-2-phenyl-2-cyclobuten-1-one
  参考文献：
  名称：

  Novel 1,2-diarylcyclobutenes: Selective and orally active cox-2 inhibitors

  摘要：

  A series of novel 2,3-diaryl-2-cyclobuten-1-ones have been synthesized and have been evaluated with respect to their ability to inhibit the isozymes of cyclooxygenase, COX-I and COX-2. 4,4-Dimethyl-2-phenyl-3- [4-(methylsulfonyl)phenyl]cyclobutenone 22 was found to be highly selective for inhibition of COX-2 and was orally active (ED(50) = 2.4 mg/kg) in the rat paw edema model. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00501-x

文献信息

• Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors
  申请人：Merck Frosst Canada, Inc.

  公开号：US05817700A1

  公开（公告）日：1998-10-06

  The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

  该发明涵盖了化合物I的新颖化合物，可用于治疗环氧合酶-2介导的疾病。 该发明还涵盖了用于治疗环氧合酶-2介导的疾病的某些药物组合，其中包括化合物I。
• SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS
  申请人：King Clifford Riley

  公开号：US20140178480A1

  公开（公告）日：2014-06-26

  Drug substances comprising a amine containing pharmaceutically active compound, and at least one of an alditol acetal and an aromatic organic acid as an addition salt or an additive.

  含有胺基药用活性化合物的药物物质，以及至少一种醛糖醚和芳香有机酸中的一种作为附加盐或添加剂。
• Compositions and articles comprising asymmetric dipolar multi-substituted alditol derivatives
  申请人：——

  公开号：US20030114558A1

  公开（公告）日：2003-06-19

  Certain multi-substituted dibenzylidene sorbitol acetals having electron withdrawing groups as constituents and electron donating groups on the other such that the compounds are asymmetric in structure and are dipolar in nature are provided. Polymer compositions comprising such compounds, are also contemplated which may be utilized within, as merely examples, food or cosmetic containers and packaging. These inventive asymmetric dipolar dibenzylidene sorbitol acetals are also useful as gelling agents for water and organic solvents, particularly those used in the preparation of antiperspirant gel sticks.

  本发明提供了某些多取代二苄基山梨醇缩醛，其组成成分具有退电子基团，另一组成成分具有供电子基团，从而使化合物结构不对称且具有双极性。此外，还考虑了包含此类化合物的聚合物组合物，这些组合物可用于食品或化妆品容器和包装（仅举例说明）。这些本发明的不对称双极性二亚苄基山梨醇缩醛还可用作水和有机溶剂的胶凝剂，特别是用于制备止汗凝胶棒的胶凝剂。
• Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
  申请人：Sen Nilendu

  公开号：US20050100594A1

  公开（公告）日：2005-05-12

  Disclosed is an extended release pharmaceutical formulation comprising a muscle relaxant drug, such as tizanidine, in combination with a cyclooxygenase-2 inhibitor, such as valdecoxib. The formulations are useful in the treatment and management of painful inflammatory conditions associated with, for example, skeletal muscle spasms.

  本发明公开了一种缓释药物制剂，该制剂由肌肉松弛剂药物（如替扎尼丁）与环氧化酶-2 抑制剂（如伐地昔布）组合而成。该制剂可用于治疗和控制与骨骼肌痉挛等相关的疼痛性炎症。
• Topical pharmaceutical compositions
  申请人：Krishnan Anandi

  公开号：US20050096371A1

  公开（公告）日：2005-05-05

  A hydroalcoholic topical pharmaceutical composition is provided comprising a therapeutically effective amount of a therapeutic agent comprising one or more selective cyclooxygenase-2 (COX-2) inhibitors or pharmaceutically acceptable salts or esters thereof solubilized in a solubilizing amount of a penetration vehicle system comprising a skin penetration enhancing effective amount of at least one monohydric alcohol and at least two non-volatile organic compounds selected from the group consisting of pyrrolidones, polyol ethers, polyols and mixtures thereof. Also provided is a process for its preparation.

  本发明提供了一种水醇局部药物组合物，该组合物包含治疗有效量的治疗剂，该治疗剂包含一种或多种选择性环氧化酶-2 (COX-2) 抑制剂或其药学上可接受的盐或酯，该治疗剂溶解在渗透载体系统的溶解量中，该渗透载体系统包含皮肤渗透增强有效量的至少一种一元醇和至少两种非挥发性有机化合物，这些非挥发性有机化合物选自由吡咯烷酮、多元醇醚、多元醇及其混合物组成的组。此外，还提供了一种制备方法。